Status:

COMPLETED

Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients

Lead Sponsor:

Gulhane Training and Research Hospital

Conditions:

Sepsis

Septic

Eligibility:

All Genders

18+ years

Brief Summary

In intensive care units, sepsis, which can be defined as bacteremia and the irregular and uncontrolled inflammatory response to it, is one of the most important causes of mortality. Early recognition ...

Eligibility Criteria

Inclusion

  • Positive blood culture during their follow up
  • Patients over 18 years of age

Exclusion

  • Those under the age of 18
  • Those who have had surgery or trauma in the last 72 hours
  • Those with a history of autoimmune disease, chronic renal failure
  • Patients admitted to intensive care due to acute pancreatitis, pregnancy, burns.
  • Patients with incomplete data.

Key Trial Info

Start Date :

March 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 19 2025

Estimated Enrollment :

1529 Patients enrolled

Trial Details

Trial ID

NCT06958354

Start Date

March 15 2023

End Date

October 19 2025

Last Update

December 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gulhane Training and Research Hospital

Ankara, Türkiye, Turkey (Türkiye), 06010